SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-13-045361
Filing Date
2013-05-29
Accepted
2013-05-29 17:03:50
Documents
11
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a13-13348_110k.htm 10-K 845030
2 EX-31.1 a13-13348_1ex31d1.htm EX-31.1 13497
3 EX-31.2 a13-13348_1ex31d2.htm EX-31.2 13077
4 EX-32.1 a13-13348_1ex32d1.htm EX-32.1 6528
5 EX-32.2 a13-13348_1ex32d2.htm EX-32.2 6091
  Complete submission text file 0001104659-13-045361.txt   3841774

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20130228.xml EX-101.INS 375474
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20130228.xsd EX-101.SCH 41208
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20130228_cal.xml EX-101.CAL 34532
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20130228_def.xml EX-101.DEF 128757
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20130228_lab.xml EX-101.LAB 504934
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20130228_pre.xml EX-101.PRE 239183
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 13878911
SIC: 2835 In Vitro & In Vivo Diagnostic Substances